LH Labcorp Holdings Inc. Common Stock

NYSE · Health Care · Auf SEC EDGAR ansehen ↗
$329,07
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026

Über Labcorp Holdings Inc. Common Stock Unternehmensübersicht von Wikipedia

LabCorp ist ein US-amerikanisches Unternehmen das klinische Labordienstleistungen anbietet. Das Unternehmen liefert Laborbefunde für die Diagnostik von Erkrankungen und die Entwicklung neuer Arzneimittel.

Mehr lesen

LabCorp (offizielle Firma: Laboratory Corporation of America Holdings) ist ein US-amerikanisches Unternehmen das klinische Labordienstleistungen anbietet. Das Unternehmen liefert Laborbefunde für die Diagnostik von Erkrankungen und die Entwicklung neuer Arzneimittel.

Laboratory Corporation of America Holdings entstand 1995 durch eine Fusion zwischen den Unternehmen National Health Laboratories (NHL), eine ehemalige Tochter von Revlon, und Roche Biomedical Laboratories (RBL), ein ehemaliger Geschäftsbereich von Hoffmann-La Roche. Durch diese Fusion entstand mit LabCorp der weltweit größte Anbieter klinischer Labordienstleistungen. In den folgenden Jahren erfolgte eine Vielzahl von Unternehmensakquisen, wie die Übernahme von Covance im Jahr 2015.

== Einzelnachweise ==

Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

LH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$329.07
Marktkapitalisierung
$27.05B
P/E (TTM)
31.5
EPS (TTM)
$10.46
Umsatz (TTM)
$13.95B
Dividendenrendite
0.89%
ROE
10.3%
Verschuldungsgrad
0.6
52W-Spanne
$245 – $329

LH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $13.95B
10-point trend, +46.0%
2016-12-31 2025-12-31
EPS $10.46
10-point trend, +53.4%
2016-12-31 2025-12-31
Freier Cashflow $1.21B
9-point trend, +34.4%
2016-12-31 2025-12-31
Margen 6.3%
9-point trend, -12.8%
2016-12-31 2025-12-31

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
LH
Peer-Median
P/E (TTM)
5-point trend, +116.7%
31.5
32.6
P/S (TTM) (K/V (TTM))
5-point trend, +24.7%
1.9
2.0
P/B (K/B)
5-point trend, +16.3%
3.1
4.4
EV / EBITDA
5-point trend, +34.5%
15.5
Price / FCF (Kurs / FCF)
5-point trend, +35.4%
22.4

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
LH
Peer-Median
Gross Margin (Bruttogewinnmarge)
5-point trend, -17.6%
28.8%
28.8%
Operating Margin (Betriebsgewinnmarge)
5-point trend, -50.9%
9.9%
Net Profit Margin (Nettogewinnmarge)
5-point trend, -57.4%
6.3%
2.4%
ROA
5-point trend, -59.4%
4.8%
4.5%
ROE
5-point trend, -55.0%
10.3%
10.9%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
LH
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
5-point trend, +22.9%
0.6
Current Ratio (Liquiditätsgrad)
5-point trend, -25.7%
1.4
1.7
Quick Ratio
5-point trend, -30.4%
0.9

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
LH
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +6.2%
7.2%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +6.2%
5.5%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +6.2%
-0.04%
EPS YoY (EPS VjV)
5-point trend, -57.1%
18.3%
Net Income YoY (Nettogewinn YoY)
5-point trend, -63.1%
17.5%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
LH
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, -57.1%
$10.46

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
LH
Peer-Median
Payout Ratio (Ausschüttungsquote)
2-point trend, -15.7%
27.5%

Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR

Dividendenrendite
0.89%
Ausschüttungsquote
27.5%
5J Div CAGR
Ex-DatumBetrag
29. Mai 2026$0,7200
27. Februar 2026$0,7200
26. November 2025$0,7200
28. August 2025$0,7200
29. Mai 2025$0,7200
27. Februar 2025$0,7200
26. November 2024$0,7200
29. August 2024$0,7200
24. Mai 2024$0,7200
26. Februar 2024$0,7200
7. November 2023$0,7200
7. August 2023$0,7200
17. Mai 2023$0,6186
22. Februar 2023$0,6186
16. November 2022$0,6186
17. August 2022$0,6186
18. Mai 2022$0,6186
29. März 1994$0,1718
29. Dezember 1993$0,1718
29. September 1993$0,1718

LH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 27 Analysten
  • Starker Kauf 9 33,3%
  • Kauf 12 44,4%
  • Halten 6 22,2%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

16 Analysten · 2026-08-15
Median-Ziel $350.00 +6,4%
Mittelwert-Ziel $337.75 +2,6%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.01%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $4.99 $4.92 0.07%
31. März 2026 $4.25 $4.21 0.04%
31. Dezember 2025 $4.07 $4.06 0.01%
30. September 2025 $4.18 $4.26 -0.08%
30. Juni 2025 $4.35 $4.29 0.06%
31. März 2025 $3.84 $3.85 -0.01%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
LH $20.62B 24.0 7.2% 6.3% 10.3% 28.8%
CVS $100.87B 57.1 7.8% 0.44% 2.4%
CI $72.51B 12.4 11.2% 2.2% 14.4%
DGX $19.09B 19.8 11.8% 9.0% 14.2%
GH $13.34B -30.8 32.9% -42.4% 205.7%
BTSG $7.20B 43.0 28.2% 1.5% 10.8% 11.8%
DVA $7.79B 11.5 6.5% 5.5% -281.8%
HNGE $0 -6.0 50.6% -89.9% -299.8% 79.7%
CHE 23.3 4.1% 10.5% 24.4%
HIMS 63.7 59.0% 5.5% 23.3% 73.8%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 14
Jährliche Gewinn- und Verlustrechnung-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +132.1% $13.95B $13.01B $12.16B $11.86B $13.14B $13.98B $11.55B $11.33B $10.31B $9.55B $8.68B $6.01B
Cost of Revenue 12-point trend, +161.0% $9.94B $9.38B $8.80B $8.15B $8.14B $9.03B $8.30B $8.16B $7.22B $6.70B $5.60B $3.81B
Gross Profit 12-point trend, +82.1% $4.01B $3.62B $3.36B $3.71B $4.99B $4.95B $3.25B $3.18B $3.09B $2.85B $2.90B $2.20B
SG&A Expense 12-point trend, +85.0% $2.22B $2.23B $2.02B $1.76B $1.69B $1.73B $1.62B $1.57B $1.50B $1.35B $1.63B $1.20B
Operating Income 12-point trend, +52.1% $1.38B $1.09B $726M $1.44B $3.05B $2.45B $1.33B $1.33B $1.31B $1.27B $997M $910M
Interest Expense 12-point trend, +104.7% $224M $208M $200M $180M $212M $207M $241M $244M $235M $219M $275M $110M
Other Non-op 12-point trend, -628.8% $-55M $60M $16M $-32M $16M $-32M $-3M $168M $-6M $12M $-8M $10M
Income Tax 12-point trend, -26.8% $230M $212M $188M $234M $690M $662M $280M $384M $-155M $361M $287M $314M
Net Income 12-point trend, +71.5% $876M $746M $418M $1.28B $2.38B $1.56B $824M $884M $1.23B $712M $438M $511M
EPS (Basic) 12-point trend, +74.8% $10.54 $8.89 $4.80 $14.05 $24.60 $15.99 $8.42 $8.71 $11.99 $6.94 $4.43 $6.03
EPS (Diluted) 12-point trend, +77.0% $10.46 $8.84 $4.77 $13.97 $24.39 $15.88 $8.35 $8.61 $11.81 $6.82 $4.35 $5.91
Shares (Basic) 12-point trend, -1.9% 83,200,000 83,900,000 87,100,000 91,100,000 96,700,000 97,300,000 97,900,000 101,400,000 102,400,000 102,500,000 98,800,000 84,800,000
Shares (Diluted) 12-point trend, -3.0% 83,800,000 84,400,000 87,600,000 91,600,000 97,500,000 98,000,000 98,600,000 102,600,000 103,900,000 104,300,000 100,600,000 86,400,000
EBITDA 11-point trend, +78.7% $2.07B $1.73B $1.30B $2.41B $4.00B $3.07B · $1.88B $1.90B $1.81B $1.46B $1.16B
Bilanz 28
Jährliche Bilanz-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, -8.2% $532M $1.52B $537M $321M $1.47B $1.32B $338M $427M $317M $434M $716M $580M
Receivables 12-point trend, +157.9% $2.10B $1.94B $1.91B $1.79B $2.26B $2.48B $1.54B $1.47B $1.53B $1.33B $1.22B $816M
Inventory 12-point trend, +283.3% $535M $493M $475M $471M $401M $423M $245M $237M $227M $205M $191M $140M
Prepaid Expense 12-point trend, +339.9% $693M $698M $655M $610M $478M $365M $374M $309M $309M $321M $339M $158M
Current Assets 12-point trend, +137.5% $4.02B $4.81B $3.77B $4.62B $5.33B $5.13B $2.98B $2.84B $2.73B $2.48B $2.62B $1.69B
PP&E (Net) 12-point trend, +291.8% $3.08B $3.05B $2.91B $2.79B $2.82B $2.73B $2.64B $1.74B $1.71B $1.72B $1.75B $786M
PP&E (Gross) 12-point trend, +250.3% $6.35B $6.12B $5.82B $5.38B $5.23B $4.93B $4.57B $3.48B $3.27B $3.11B $2.87B $1.81B
Accum. Depreciation 12-point trend, +218.6% $3.27B $3.07B $2.91B $2.58B $2.41B $2.20B $1.93B $1.74B $1.56B $1.39B $1.12B $1.03B
Goodwill 12-point trend, +9.5% $6.79B $6.37B $6.14B $6.12B $5.89B $7.75B $7.87B $7.36B $7.40B $6.42B $6.42B $6.20B
Intangibles 12-point trend, +143.7% $3.60B $3.49B $3.34B $3.12B $3.74B $3.96B $4.03B $3.91B $4.17B $3.40B $3.32B $1.48B
Other Non-current Assets 12-point trend, +385.3% $751M $652M $536M $378M $463M $410M $435M $276M $218M $165M $150M $155M
Total Assets 12-point trend, +151.9% $18.39B $18.38B $16.73B $20.16B $20.39B $20.07B $18.05B $16.19B $16.67B $14.25B $14.10B $7.30B
Accounts Payable 12-point trend, +197.8% $841M $876M $828M $852M $621M $639M $632M $635M $574M $508M $497M $282M
Accrued Liabilities 12-point trend, +148.3% $848M $871M $804M $787M $1.40B $1.36B $942M $870M $793M $594M $633M $341M
Short-term Debt 10-point trend, +300000.00 $300.0K $400.0K $1M $2M $2M $2M $2M $2M $2M $0 · ·
Current Liabilities 12-point trend, +189.2% $2.82B $3.33B $3.23B $3.08B $2.78B $3.08B $2.66B $1.88B $2.19B $1.83B $1.70B $976M
Capital Leases 12-point trend, +1641.3% $683M $676M $649M $653M $642M $678M $597M $0 $58M $56M $56M $39M
Other Non-current Liabilities 12-point trend, +136.3% $648M $517M $409M $401M $402M $526M $383M $334M $376M $392M $323M $274M
Total Liabilities 12-point trend, +118.6% $9.76B $10.31B $8.83B $10.04B $10.09B $10.61B $10.46B $9.19B $9.85B $8.73B $9.14B $4.46B
Long-term Debt 8-point trend, +86.9% $5.58B $6.33B · · · · $6.21B $6.00B $6.70B $5.78B $6.36B $2.99B
Total Debt 11-point trend, +84.5% $5.58B $5.33B $4.05B $5.04B $5.42B $5.42B · $6.05B $6.76B $5.84B $6.41B $3.03B
Common Stock 12-point trend, -27.9% $8M $8M $8M $8M $8M $9M $9M $12M $12M $12M $12M $10M
Retained Earnings 12-point trend, +128.2% $8.64B $8.30B $7.89B $10.58B $10.46B $9.48B $7.98B $7.16B $6.20B $4.97B $4.22B $3.79B
Treasury Stock 6-point trend, -100.0% · · · · · · $0 $1.11B $1.06B $1.01B $978M $966M
AOCI 12-point trend, -162.9% $-28M $-262M $-59M $-493M $-192M $-162M $-372M $-463M $-334M $-582M $-287M $-10M
Stockholders' Equity 12-point trend, +205.6% $8.62B $8.05B $7.88B $10.10B $10.27B $9.44B $7.64B $7.05B $6.80B $5.52B $4.95B $2.82B
Liabilities + Equity 12-point trend, +151.9% $18.39B $18.38B $16.73B $20.16B $20.39B $20.07B $18.05B $16.19B $16.67B $14.25B $14.10B $7.30B
Shares Outstanding 12-point trend, -2.8% 82,200,000 83,400,000 83,900,000 88,200,000 93,100,000 97,500,000 97,200,000 98,900,000 101,900,000 102,700,000 101,300,000 84,600,000
Cashflow 18
Jährliche Cashflow-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +177.4% $681M $644M $577M $537M $577M $625M $577M $552M $533M $499M $458M $246M
Stock-based Comp 12-point trend, +175.3% $126M $117M $129M $117M $133M $112M $107M $92M $110M $110M $102M $46M
Deferred Tax 12-point trend, +252.3% $98M $-20M $-78M $24M $-38M $-47M $29M $33M $-542M $55M $-34M $28M
Amort. of Intangibles 12-point trend, +265.1% $280M $256M $220M $194M $230M $275M $243M $232M $216M $180M $164M $77M
Restructuring 10-point trend, +194.7% · · $56M $56M $44M $33M $33M $52M $76M $65M $114M $19M
Other Non-cash 11-point trend, -54.2% $-140M $100M $282M $-108M $-88M $-110M · $-244M $74M $-220M $19M $-91M
Operating Cash Flow 12-point trend, +122.0% $1.64B $1.59B $1.33B $1.96B $3.11B $2.14B $1.44B $1.31B $1.50B $1.20B $982M $739M
CapEx 12-point trend, +113.5% $434M $490M $454M $429M $422M $382M $400M $380M $313M $279M $256M $204M
Investing Cash Flow 12-point trend, -241.0% $-1.19B $-1.37B $-1.17B $-1.65B $-885M $-643M $-1.28B $207M $-2.23B $-796M $-3.99B $-350M
Debt Issued 9-point trend, +0.00 · · · $0 $1.00B $0 $1.05B $0 $1.20B $0 $2.90B $0
Net Debt Issued 8-point trend, +0.00 · · · $0 $1.00B $0 · $0 $1.20B $0 $2.90B $0
Stock Repurchased 12-point trend, +67.3% $450M $250M $1.00B $1.10B $1.67B $100M $450M $700M $338M $44M $0 $269M
Net Stock Activity 11-point trend, -67.3% $-450M $-250M $-1.00B $-1.10B $-1.67B $-100M · $-700M $-338M $-44M $0 $-269M
Dividends Paid 4-point trend, +23.3% $241M $243M $254M $195M · · · · · · · ·
Financing Cash Flow 12-point trend, -626.3% $-1.46B $780M $-59M $-1.32B $-2.07B $-517M $-253M $-1.39B $593M $-671M $3.18B $-201M
Net Change in Cash 12-point trend, -660.5% $-986M $982M $107M $-1.04B $152M $983M $-89M $110M $-117M $-283M $136M $176M
Taxes Paid 12-point trend, -39.8% $171M $215M $207M $475M $965M $500M $217M $350M $348M $346M $238M $284M
Free Cash Flow 11-point trend, +125.2% $1.21B $1.10B $874M $1.47B $2.65B $1.75B · $926M $1.15B $897M $727M $536M
Rentabilität 6
Jährliche Rentabilität-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Gross Margin 11-point trend, -21.5% 28.8% 27.9% 27.7% 29.5% 34.9% 35.4% · 28.0% 33.2% 33.0% 33.5% 36.6%
Operating Margin 11-point trend, -34.5% 9.9% 8.3% 6.0% 11.9% 20.2% 17.5% · 11.7% 13.1% 13.6% 11.6% 15.1%
Net Margin 11-point trend, -26.1% 6.3% 5.7% 3.4% 8.6% 14.8% 11.1% · 7.8% 12.2% 7.6% 5.0% 8.5%
EBITDA Margin 11-point trend, -23.0% 14.8% 13.3% 10.7% 16.2% 24.8% 22.0% · 16.6% 18.2% 18.8% 16.8% 19.2%
ROA 11-point trend, -33.5% 4.8% 4.2% 2.3% 6.3% 11.8% 8.2% · 5.4% 8.2% 5.2% 4.1% 7.2%
ROE 11-point trend, -43.9% 10.3% 9.2% 5.3% 12.7% 22.8% 17.7% · 12.4% 19.6% 13.2% 9.0% 18.3%
Liquidität & Solvenz 5
Jährliche Liquidität & Solvenz-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -17.9% 1.4 1.4 1.2 1.5 1.9 1.7 · 1.5 1.3 1.4 1.6 1.7
Quick Ratio 11-point trend, -34.7% 0.9 1.0 0.8 0.9 1.3 1.2 · 1.0 0.9 1.0 1.1 1.4
Debt / Equity 11-point trend, -39.6% 0.6 0.7 0.5 0.5 0.5 0.6 · 0.9 1.0 1.1 1.3 1.1
LT Debt / Equity 11-point trend, -38.0% 0.6 0.7 0.5 0.5 0.5 0.6 · 0.9 0.9 1.0 1.2 1.0
Interest Coverage 11-point trend, -25.7% 6.2 5.2 3.6 9.8 15.4 11.8 · 5.4 5.8 6.0 3.6 8.3
Effizienz 3
Jährliche Effizienz-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -10.0% 0.8 0.7 0.7 0.7 0.8 0.7 · 0.7 0.7 0.7 0.8 0.8
Inventory Turnover 11-point trend, -29.9% 19.3 19.4 18.6 24.1 25.5 27.0 · 35.1 31.2 31.6 33.9 27.6
Receivables Turnover 11-point trend, -8.2% 6.9 6.7 6.6 6.6 6.8 6.9 · 7.6 7.4 7.6 8.5 7.5
Pro Aktie 6
Jährliche Pro Aktie-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 7-point trend, +214.5% $104.86 $96.55 · · · · · $70.49 $67.03 $53.61 $48.81 $33.34
Revenue / Share 11-point trend, +139.3% $166.49 $154.13 $138.83 $162.41 $165.34 $142.64 · $110.46 $100.49 $92.44 $86.28 $69.58
Cash Flow / Share 11-point trend, +128.9% $19.58 $18.79 $15.16 $21.35 $31.89 $21.79 · $12.72 $14.05 $11.27 $9.77 $8.55
Cash / Share 7-point trend, -5.5% $6.48 $18.21 · · · · · $4.32 $3.11 $4.22 $7.07 $6.86
Dividend Paid / Share 4-point trend, +33.3% $3 $3 $3 $2 · · · · · · · ·
EPS (TTM) 12-point trend, +77.0% $10.46 $8.84 $4.77 $13.97 $24.39 $15.88 $8.35 $8.61 $11.81 $6.82 $4.35 $5.91
Wachstumsraten 9
Jährliche Wachstumsraten-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +220.2% 7.2% 7.0% 2.5% -9.7% -6.0% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +222.2% 5.5% -0.32% -4.5% · · · · · · · · ·
Revenue CAGR 5Y -0.04% · · · · · · · · · · ·
EPS YoY 5-point trend, -65.8% 18.3% 85.3% -65.9% -42.7% 53.6% · · · · · · ·
EPS CAGR 3Y 3-point trend, +72.2% -9.2% -28.7% -33.0% · · · · · · · · ·
EPS CAGR 5Y -8.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -66.9% 17.5% 78.5% -67.3% -46.2% 52.8% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +66.6% -11.8% -32.0% -35.5% · · · · · · · · ·
Net Income CAGR 5Y -10.8% · · · · · · · · · · ·
Bewertung (TTM) 16
Jährliche Bewertung (TTM)-Daten für LH
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +132.1% $13.95B $13.01B $12.16B $11.86B $13.14B $13.98B $11.55B $11.33B $10.31B $9.55B $8.68B $6.01B
Net Income TTM 12-point trend, +71.5% $876M $746M $418M $1.28B $2.38B $1.56B $824M $884M $1.23B $712M $438M $511M
Market Cap 7-point trend, +163.0% $20.62B $19.13B · · · · · $10.74B $13.96B $11.33B $10.76B $7.84B
Enterprise Value 7-point trend, +149.5% $25.68B $22.94B · · · · · $16.36B $20.40B $16.73B $16.46B $10.29B
P/E 12-point trend, +52.9% 24.0 25.9 47.6 14.5 11.1 11.0 17.4 12.6 11.6 16.2 24.4 15.7
P/S 7-point trend, +13.3% 1.5 1.5 · · · · · 0.9 1.4 1.2 1.2 1.3
P/B 7-point trend, -14.0% 2.4 2.4 · · · · · 1.5 2.0 2.1 2.2 2.8
P / Cash Flow 7-point trend, +18.5% 12.6 12.1 · · · · · 8.2 9.6 9.6 11.0 10.6
P / FCF 7-point trend, +16.8% 17.1 17.5 · · · · · 11.6 12.2 12.6 14.8 14.6
EV / EBITDA 7-point trend, +39.6% 12.4 13.3 · · · · · 8.7 10.8 9.2 11.3 8.9
EV / FCF 7-point trend, +10.8% 21.3 20.9 · · · · · 17.7 17.8 18.7 22.6 19.2
EV / Revenue 7-point trend, +7.5% 1.8 1.8 · · · · · 1.4 2.0 1.8 1.9 1.7
Dividend Yield 2-point trend, -7.9% 1.2% 1.3% · · · · · · · · · ·
Earnings Yield 12-point trend, -34.6% 4.2% 3.9% 2.1% 6.9% 9.0% 9.1% 5.8% 7.9% 8.6% 6.2% 4.1% 6.4%
Payout Ratio 2-point trend, -15.7% 27.5% 32.6% · · · · · · · · · ·
Annual Payout 4-point trend, +23.3% $241M $243M $254M $195M · · · · · · · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $13.95B$13.01B$12.16B$11.86B$13.14B
Bruttogewinnmarge % 28.8%27.9%27.7%29.5%34.9%
Betriebsgewinnmarge % 9.9%8.3%6.0%11.9%20.2%
Nettoergebnis $876M$746M$418M$1.28B$2.38B
Verwässerte EPS $10.46$8.84$4.77$13.97$24.39
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fremdkapital / Eigenkapital 0.60.70.50.50.5
Liquiditätsgrad 1.41.41.21.51.9
Quick Ratio 0.91.00.80.91.3
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $1.21B$1.10B$874M$1.47B$2.65B

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 1.137 Einreicher · $13.9B gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
115 (-10 vs. Vorquartal) 67 (-19 vs. Vorquartal) 346 (+20 vs. Vorquartal) 375 (+20 vs. Vorquartal) +9.2M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
VANGUARD CAPITAL MANAGEMENT LLC $1.501.431.120 5.362.254 10,83% Aktien
VICTORY CAPITAL MANAGEMENT INC $1.322.911.874 4.724.673 9,54% Aktien
STATE STREET CORP $1.094.143.680 3.907.656 7,89% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $1.030.063.440 3.678.798 7,43% Aktien
Select Equity Group, L.P. $554.945.440 1.981.948 4,00% Aktien
GEODE CAPITAL MANAGEMENT, LLC $535.196.252 1.920.148 3,86% Aktien
FMR LLC $367.740.272 1.313.358 2,65% Aktien
DIMENSIONAL FUND ADVISORS LP $323.956.098 1.156.986 2,34% Aktien
AMERICAN CENTURY COMPANIES INC $236.607.011 845.023 1,71% Aktien
NORGES BANK $226.826.040 810.093 1,64% Aktien
WELLINGTON MANAGEMENT GROUP LLP $224.168.560 800.602 1,62% Aktien
Navera Investment Management Ltd. $218.923.069 781.731 1,58% Aktien
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $207.766.160 742.022 1,50% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $178.985.240 639.233 1,29% Aktien
BECK MACK & OLIVER LLC $169.468.040 605.243 1,22% Aktien
Diamond Hill Capital Management, LLC (Investment Advisor) $168.221.760 600.792 1,21% Aktien
River Road Asset Management, LLC $164.943.800 589.085 1,19% Aktien
Woodline Partners LP $155.964.480 557.016 1,12% Aktien
COOKE & BIELER LP $147.077.840 525.278 1,06% Aktien
Madison Asset Management, LLC $133.459.991 476.643 0,96% Aktien
EARNEST PARTNERS LLC $133.421.680 476.506 0,96% Aktien
VANGUARD FIDUCIARY TRUST CO $128.924.880 460.446 0,93% Aktien
NORDEA INVESTMENT MANAGEMENT AB $123.800.108 445.164 0,89% Aktien
Madison Investment Advisors, LLC $123.415.073 538.178 0,89% Aktien
VANGUARD GROUP INC $116.373.949 463.863 0,84% Aktien
ALLIANCEBERNSTEIN L.P. $111.629.302 418.385 0,80% Aktien
JONES FINANCIAL COMPANIES LLLP $109.064.801 401.756 0,79% Aktien
LAZARD ASSET MANAGEMENT LLC $90.836.480 324.416 0,65% Aktien
BANK OF AMERICA CORP /DE/ $86.222.640 307.938 0,62% Aktien
ENVESTNET ASSET MANAGEMENT INC $74.910.586 267.538 0,54% Aktien
Squarepoint Ops LLC $72.362.640 258.438 0,52% Aktien
Swiss National Bank $65.077.600 232.420 0,47% Aktien
MILLENNIUM MANAGEMENT LLC $63.852.040 228.043 0,46% Aktien
FAIRVIEW CAPITAL INVESTMENT MANAGEMENT, LLC $63.265.026 225.946 0,46% Aktien
JOHNSON INVESTMENT COUNSEL INC $61.244.676 218.731 0,44% Aktien
Legal & General Group Plc $61.101.879 218.221 0,44% Aktien
Sumitomo Mitsui Trust Group, Inc. $58.984.800 210.660 0,43% Aktien
CAMBIAR INVESTORS LLC $57.636.600 205.845 0,42% Aktien
BARTLETT & CO. WEALTH MANAGEMENT LLC $57.282.012 204.579 0,41% Aktien
Mitsubishi UFJ Asset Management Co., Ltd. $55.989.360 199.962 0,40% Aktien
UBS Group AG $53.732.840 191.903 0,39% Aktien
Vanguard Global Advisers, LLC $49.589.120 177.104 0,36% Aktien
AMI ASSET MANAGEMENT CORP $47.755.417 170.555 0,34% Aktien
BlackRock, Inc. $45.950.520 164.109 0,33% Aktien
VANGUARD ASSET MANAGEMENT, Ltd $44.792.720 159.974 0,32% Aktien
BNP PARIBAS FINANCIAL MARKETS $44.597.000 159.275 0,32% Aktien
California Public Employees Retirement System $44.287.320 158.169 0,32% Aktien
RHUMBLINE ADVISERS $42.279.160 150.997 0,30% Aktien
Cannell & Spears LLC $42.010.360 150.037 0,30% Aktien
Point72 Asset Management, L.P. $38.484.320 137.444 0,28% Aktien
DAVIDSON INVESTMENT ADVISORS $37.211.477 132.898 0,27% Aktien
Sequoia Financial Advisors, LLC $35.624.746 127.231 0,26% Aktien
EVERETT HARRIS & CO /CA/ $34.912.920 124.689 0,25% Aktien
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $32.145.269 120.480 0,23% Aktien
NEW YORK STATE COMMON RETIREMENT FUND $32.070.360 114.537 0,23% Aktien
WS MANAGEMENT LLLP $31.792.880 113.546 0,23% Aktien
Allianz Asset Management GmbH $29.362.760 104.867 0,21% Aktien
WEDGE CAPITAL MANAGEMENT L L P/NC $28.770.656 107.832 0,21% Aktien
WEITZ INVESTMENT MANAGEMENT, INC. $27.734.000 99.050 0,20% Aktien
AMERIPRISE FINANCIAL INC $26.314.413 93.980 0,19% Aktien
Burgundy Asset Management Ltd. $25.977.610 93.448 0,19% Aktien
Universal- Beteiligungs- und Servicegesellschaft mbH $25.697.280 91.776 0,19% Aktien
Gotham Asset Management, LLC $25.402.160 90.722 0,18% Aktien
PRINCIPAL FINANCIAL GROUP INC $24.804.360 88.587 0,18% Aktien
Quantinno Capital Management LP $24.191.241 86.397 0,17% Aktien
ZACKS INVESTMENT MANAGEMENT $23.959.139 85.568 0,17% Aktien
MCRAE CAPITAL MANAGEMENT INC $22.704.964 81.089 0,16% Aktien
ASSETMARK, INC $22.566.303 80.594 0,16% Aktien
GOLDMAN SACHS GROUP INC $21.611.240 77.183 0,16% Aktien
BARCLAYS PLC $21.561.960 77.007 0,16% Aktien
Cerity Partners LLC $21.505.977 76.807 0,16% Aktien
Willis Investment Counsel $21.089.320 75.319 0,15% Aktien
RAYMOND JAMES FINANCIAL INC $20.982.380 74.937 0,15% Aktien
Eurizon Capital SGR S.p.A. $20.852.912 74.478 0,15% Aktien
FIL Ltd $20.182.120 72.079 0,15% Aktien
AVIVA PLC $20.142.920 71.939 0,15% Aktien
Stack Financial Management, Inc $20.091.299 71.755 0,14% Aktien
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $19.724.320 70.444 0,14% Aktien
Qube Research & Technologies Ltd $19.709.760 70.392 0,14% Aktien
HighTower Advisors, LLC $19.479.174 69.568 0,14% Aktien
Assenagon Asset Management S.A. $19.405.400 69.305 0,14% Aktien
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $19.013.120 67.904 0,14% Aktien
PINEBRIDGE INVESTMENTS LLC $18.194.680 64.981 0,13% Aktien
Busey Bank $17.876.320 63.844 0,13% Aktien
Mill Capital Management, LLC $17.548.720 62.674 0,13% Aktien
OAK ASSOCIATES LTD /OH/ $17.529.960 62.607 0,13% Aktien
STIFEL FINANCIAL CORP $17.456.357 62.343 0,13% Aktien
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $17.450.975 65.406 0,13% Aktien
Boston Partners $17.008.690 60.721 0,12% Aktien
BROWN ADVISORY INC $16.968.306 60.601 0,12% Aktien
LPL Financial LLC $16.940.224 60.501 0,12% Aktien
Heron Bay Capital Management $16.678.445 59.566 0,12% Aktien
AQR CAPITAL MANAGEMENT LLC $16.604.130 59.830 0,12% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $15.988.000 57.100 0,12% Verkaufsoption
FIFTH THIRD BANCORP $15.700.163 56.072 0,11% Aktien
Swedbank AB $15.484.000 55.300 0,11% Aktien
Ironvine Capital Partners, LLC $15.349.320 54.819 0,11% Aktien
FRANKLIN RESOURCES INC $15.318.240 54.708 0,11% Aktien
SPEECE THORSON CAPITAL GROUP INC $15.228.000 54.385 0,11% Aktien
NATIXIS $15.115.240 53.983 0,11% Aktien

Unternehmensinsider 66 Insider · 35 Führungskräfte · 24 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Paul R Kirchgraber CEO, Covance Drug Development 19. Mai 2023 M 12.946 0 0 $0
Thomas Pike Pres & CEO Clinical Business 9. Januar 2023 A 0 0 $0
John D Ratliff CEO, Covance Drug Development 3. April 2019 M 16.941 0 0 $0
Gary M. Huff CEO, LabCorp Diagnostics 4. September 2018 M 1.850 0 0 $0
James T. Boyle Jr. EVP,CEO of LabCorp Diagnostics 31. März 2016 S 23.454 0 0 $0
Deborah L Keller CEO, Covance Drug Development 11. März 2016 M 19.754 0 0 $0
Joseph L Herring CEO of Covance Drug Division 31. Juli 2015 M 10.404 0 0 $0
Julia Aijun Wang Chief Financial Officer, EVP 11. Februar 2026 M 1.817 0 0 $0
William B Hayes Chief Financial Officer, EVP 6. Juni 2014 M 19.400 0 0 $0
Wesley R Elingburg EVP & Chief Financial Officer 4. Mai 2005 M 56.244 0 0 $0
Mark S Schroeder EVP, Pres Diagnostics & COO 26. März 2026 F 12.677 0 0 $0
Bryan T Vaughn EVP and President, Diagnostics 1. Juli 2026 M 6.746 0 1 $-66.968
Kathryn W Kyle EVP, Chief Legal Officer 1. Juli 2026 M 3.904 0 2 $-227.413
Jonathan C Meltzer EVP, Operations 27. März 2026 S 3.620 0 4 $-298.757
Akinbolade Oyegunwa EVP, CIO & CTO 26. März 2026 F 5.064 0 0 $0
Megan D. Bailey EVP, Pres, Central Labs & Intl 26. März 2026 F 4.851 0 0 $0
Brian J Caveney EVP, Pres of ED, CMO & CSO 26. März 2026 F 36.492 0 1 $-429.450
Sandra D Van Der Vaart EVP, Corporate Affairs 26. März 2026 F 6.239 0 1 $-156.131
Anita Z Graham EVP, CHRO 26. März 2026 F 5.185 0 0 $0
Glenn A Eisenberg Executive Vice President 27. März 2025 F 37.920 0 0 $0
Lance Berberian EVP, Special Advisor, Strategy 27. März 2025 F 18.652 0 0 $0
Jonathan P. Divincenzo EVP, Pres, Central Labs & Intl 27. März 2024 M 5.461 0 0 $0
Judith C Seltz EVP, CHRO 30. März 2023 F 4.182 0 0 $0
Lisa J Uthgenannt Chief Human Resources Officer 4. September 2019 M 4.660 0 0 $0
Edward T Dodson Principal Accounting Officer 1. April 2019 F 13.663 0 0 $0
Samuel F Eberts III Chief Legal Officer, Secretary 12. Februar 2019 M 28.823 0 0 $0
Mark E Brecher CMO, LabCorp Diagnostics 30. März 2015 M 5.511 0 0 $0
Lidia Fonseca Chief Information Officer 28. März 2013 F 9.087 0 0 $0
Andrew Scott Walton EVP 9. April 2012 S 22.298 0 0 $0
Don M Hardison EVP 31. Dezember 2009 F 19.928 0 0 $0
Goldman Myla Lai EVP & Chief Medical Officer 20. November 2008 G 21.991 0 0 $0
William Haas EVP, Esoterix Business 7. Mai 2008 A 44.249 0 0 $0
Benjamin R Miller EVP, Sales & Marketing 26. März 2008 F 19.927 0 0 $0
Woodrow L Cook EVP, Eastern Operations 30. Oktober 2007 M 12.535 0 0 $0
Allen W Troub EVP, Western Operations 1. März 2007 F 12.697 0 0 $0
Kerrii B Anderson Direktor 17. August 2026 S 6.563 0 1 $-954.060
Kirsten Marie Kliphouse Direktor 11. Februar 2026 M 3.160 0 0 $0
Kathryn E Wengel Direktor 11. Februar 2026 M 4.133 0 0 $0
Jeffrey A. Davis Direktor 11. Februar 2026 M 5.460 0 0 $0
Paul Rothman Direktor 11. Februar 2026 M 2.571 0 0 $0
Richelle P Parham Direktor 11. Februar 2026 M 3.366 0 1 $-1.782.249
Garheng Kong Direktor 11. Februar 2026 M 13.739 0 0 $0
Peter M Neupert Direktor 11. Februar 2026 M 13.784 0 0 $0
John H Sampson Direktor 10. Februar 2026 A 0 0 $0
Carulla Victor Bulto Direktor 10. Februar 2026 A 0 0 $0
Dwight Gary Gilliland Direktor 30. Juli 2025 S 6.656 0 0 $0
Sanders R Williams Direktor 7. Februar 2024 M 8.120 0 0 $0
Jean Luc Belingard Direktor 7. Februar 2024 M 17.781 0 0 $0
David P King Direktor 5. Mai 2020 S 312.554 0 0 $0
Robert E Mittelstaedt JR Direktor 9. Mai 2019 M 15.515 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 7 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Laboratory Corporation of America Holdings ×4 Einreichungen 24. Juli 2023 Erste Einreichung SEC
Longview Asset Management, LLC /, James A. Star, not individually but solely as President of Longview Asset Management, LLC, Geoffrey F. Grossman, not individually but solely as Trustee of the Edward Memorial Trust ×4 Einreichungen 23. Januar 2009 Erste Einreichung Passive Anlage SEC
Nicht offengelegter meldender Beteiligter 14. Mai 2002 Erste Einreichung M&A / Verkauf SEC
Nicht offengelegter meldender Beteiligter 18. März 2002 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 28. Februar 2002 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 13. Juni 2001 Erste Einreichung SEC
Nicht offengelegter meldender Beteiligter 17. Mai 2001 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 176 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
IHF · iShares Trust 3,85% 150.479 SH 8. August 2026 Täglich
ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… 2,76% 24.022 NS 30. April 2026 N-PORT
STNC · Hennessy Funds Trust 2,68% 9.570 NS 30. April 2026 N-PORT
CAMX · ADVISORS' INNER CIRCLE FUND 2,64% 6.800 NS 30. April 2026 N-PORT
BMVP · Invesco Exchange-Traded Fund Trust 1,94% 6.404 SH 8. August 2026 Täglich
RSPH · Invesco Exchange-Traded Fund Trust 1,80% 44.124 SH 8. August 2026 Täglich
EPMV · Harbor ETF Trust 1,48% 255 NS 30. April 2026 N-PORT
EPMB · Harbor ETF Trust 1,43% 250 NS 30. April 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,25% 42.553 NS 30. April 2026 N-PORT
ZECP · Zacks Trust 0,79% 10.344 NS 31. Mai 2026 N-PORT
ITAN · EA Series Trust 0,49% 1.678 NS 29. Mai 2026 N-PORT
HUSV · First Trust Exchange-Traded Fund III 0,46% 1.301 NS 30. April 2026 N-PORT
IYH · iShares Trust 0,42% 49.159 SH 8. August 2026 Täglich
AKAF · ETF Series Solutions 0,42% 47 NS 31. Mai 2026 N-PORT
VOE · VANGUARD INDEX FUNDS 0,40% 526.743 SH 8. August 2026 Täglich
COWZ · Pacer Funds Trust 0,38% 268.763 NS 30. April 2026 N-PORT
QQWZ · Pacer Funds Trust 0,37% 674 NS 30. April 2026 N-PORT
IMCV · iShares Trust 0,36% 13.159 SH 8. August 2026 Täglich
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,36% 6.135 NS 30. April 2026 N-PORT
NUMV · Nushares ETF Trust 0,35% 5.884 NS 30. April 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,34% 38.214 NS 30. April 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,34% 247.706 SH 8. August 2026 Täglich
FTA · First Trust Exchange-Traded AlphaDE… 0,33% 16.916 NS 30. April 2026 N-PORT
IXJ · iShares Trust 0,33% 43.006 SH 8. August 2026 Täglich
QUVU · Hartford Funds Exchange-Traded Trust 0,32% 2.155 NS 30. April 2026 N-PORT
RXL · ProShares Trust 0,31% 864 NS 31. Mai 2026 N-PORT
CURE · Direxion Shares ETF Trust 0,31% 1.652 NS 30. April 2026 N-PORT
ABCS · EA Series Trust 0,30% 130 NS 29. Mai 2026 N-PORT
JSTC · Tidal Trust I 0,28% 3.600 NS 31. Mai 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,27% 4.660 NS 30. April 2026 N-PORT
IWS · iShares Trust 0,25% 123.804 SH 8. August 2026 Täglich
DEUS · DBX ETF Trust 0,25% 2.590 NS 29. Mai 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,24% 13.814 NS 30. April 2026 N-PORT
SIZE · iShares Trust 0,23% 3.185 SH 8. August 2026 Täglich
AVMC · AMERICAN CENTURY ETF TRUST 0,23% 3.526 NS 31. Mai 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,22% 691.006 SH 8. August 2026 Täglich
EUSA · iShares, Inc. 0,22% 13.373 SH 8. August 2026 Täglich
VO · VANGUARD INDEX FUNDS 0,22% 1.777.108 SH 8. August 2026 Täglich
DFVE · DoubleLine ETF Trust 0,22% 223 NS 31. März 2026 N-PORT
JMOM · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 17.572 NS 30. April 2026 N-PORT
GSEW · Goldman Sachs ETF Trust 0,20% 13.515 NS 31. Mai 2026 N-PORT
SUSA · iShares Trust 0,19% 25.113 SH 8. August 2026 Täglich
IWR · iShares Trust 0,19% 334.007 SH 8. August 2026 Täglich
VLUE · iShares Trust 0,18% 54.092 SH 8. August 2026 Täglich
IMCB · iShares Trust 0,18% 9.445 SH 8. August 2026 Täglich
BSCU · Invesco Exchange-Traded Self-Indexe… 0,18% 4.740.000 8. August 2026 Täglich
EVUS · iShares Trust 0,17% 2.012 SH 8. August 2026 Täglich
FAB · First Trust Exchange-Traded AlphaDE… 0,17% 895 NS 30. April 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,15% 4.369 NS 30. April 2026 N-PORT
DFLV · Dimensional ETF Trust 0,15% 34.928 NS 30. April 2026 N-PORT